These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35211429)

  • 1. SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression.
    Cui X; Cui Y; Du T; Jiang X; Song C; Zhang S; Ma C; Liu Y; Ni Q; Gao Y; Wang G
    Can J Gastroenterol Hepatol; 2022; 2022():3758697. PubMed ID: 35211429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
    Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
    Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
    Ji L; Tang Y; Pang X; Zhang Y
    Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.
    Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W
    Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.
    Wang F; Yang YZ; Shi CZ; Zhang P; Moyer MP; Zhang HZ; Zou Y; Qin HL
    Ann Surg Oncol; 2012 Aug; 19(8):2753-62. PubMed ID: 22219067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma.
    Woo CC; Chen WC; Teo XQ; Radda GK; Lee PT
    Oncotarget; 2016 Aug; 7(33):53005-53017. PubMed ID: 27391339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy.
    Chen J; Na R; Xiao C; Wang X; Wang Y; Yan D; Song G; Liu X; Chen J; Lu H; Chen C; Tang H; Zhuang G; Fan G; Peng Z
    Oncogene; 2021 Jun; 40(23):3974-3988. PubMed ID: 33990700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncovering SIRT3 and SHMT2-dependent pathways as novel targets for apigenin in modulating colorectal cancer: In vitro and in vivo studies.
    Abdelmaksoud NM; Abulsoud AI; Abdelghany TM; Elshaer SS; Rizk SM; Senousy MA; Maurice NW
    Exp Cell Res; 2024 Aug; 441(1):114150. PubMed ID: 38971519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma.
    Wu X; Deng L; Tang D; Ying G; Yao X; Liu F; Liang G
    Tumour Biol; 2016 May; 37(5):6813-21. PubMed ID: 26662310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma.
    Clark RA; Qiao J; Jacobson JC; Chung DH
    Oncotarget; 2022; 13():32-45. PubMed ID: 35018218
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Hu B; Xian Z; Zou Q; Zhang D; Su D; Yao J; Ren D
    Cancer Biother Radiopharm; 2021 Feb; 36(1):45-57. PubMed ID: 32379550
    [No Abstract]   [Full Text] [Related]  

  • 12. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors.
    Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients.
    Shi H; Fang X; Li Y; Zhang Y
    Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT.
    Huo FC; Xie M; Zhu ZM; Zheng JN; Pei DS
    Genomics; 2022 Jul; 114(4):110424. PubMed ID: 35798250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of SHMT2 promotes the prostate cancer proliferation and metastasis by inducing epithelial-mesenchymal transition.
    Chen L; Liu H; Ji Y; Ma Z; Shen K; Shangguan X; Qian H; Zhao Y; Pan CW; Xue W
    Exp Cell Res; 2022 Jun; 415(2):113138. PubMed ID: 35398308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
    Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
    J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer proteome and metabolite changes linked to SHMT2.
    Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF
    PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.
    Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J
    Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced SHMT2 protein lactylation facilitates glycolysis and stemness of esophageal cancer cells.
    Qiao Z; Li Y; Li S; Liu S; Cheng Y
    Mol Cell Biochem; 2024 Nov; 479(11):3063-3076. PubMed ID: 38175377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoplasmic reticulum stress-dependent regulation of the expression of serine hydroxymethyltransferase 2 in glioblastoma cells.
    Minchenko OH; Sliusar MY; Khita OO; Viletska YM; Luzina OY; Danilovskyi SV; Minchenko DO
    Endocr Regul; 2024 Jan; 58(1):144-152. PubMed ID: 38861539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.